Yuan Meng

CAR-NK cells for cancer immunotherapy: from bench to bedside

Zhong-chao Han, Leisheng Zhang, Xiaoming Feng, 2022, Biomarker Research.

CD4+ T cells are required to improve the efficacy of CIK therapy in non-small cell lung cancer

X. Ren, Wenwen Yu, Baihui Li, 2022, Cell Death & Disease.

An engineered hydrogel with low-dose antitumor drugs enhances tumor immunotherapy through tumor interstitial wrap

Qiang Zhang, Z. Ao, Lanxin Jia, 2022, Frontiers in Bioengineering and Biotechnology.

Critical Role of Lkb1 in the Maintenance of Alveolar Macrophage Self-Renewal and Immune Homeostasis

Jingru Liu, Huifang Huang, E. Jiang, 2021, Frontiers in Immunology.

Homogeneously high expression of CD32b makes it a potential target for CAR-T therapy for chronic lymphocytic leukemia

Dongming Zhou, S. Zuo, Huifang Huang, 2021, Journal of Hematology & Oncology.

Short-Interval Sequential CAR-T Cell Infusion May Enhance Prior CAR-T Cell Expansion to Augment Anti-Lymphoma Response in B-NHL

Xiaoming Feng, B. Deng, Jing Pan, 2021, Frontiers in Oncology.

High-efficient generation of natural killer cells from peripheral blood with preferable cell vitality and enhanced cytotoxicity by combination of IL-2, IL-15 and IL-18.

Leisheng Zhang, Min Liu, Xiaoming Feng, 2020, Biochemical and biophysical research communications.